Clover Health Investments (CLOV) posted a Q4 diluted loss Thursday of $0.04 per share, narrowing from $0.14 a year earlier.
Four analysts polled by FactSet expected a loss of $0.07.
Revenue for the quarter ended Dec. 31 was $337 million, up from $312.4 million a year earlier.
Analysts surveyed by FactSet expected $347.4 million.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。